INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, published by SpringerNature, stands as a revered platform in the field of urology, particularly focusing on issues related to male sexual health and dysfunction. Since its inception in 1993, this journal has consistently provided cutting-edge research, reviews, and clinical studies, all directed towards advancing our understanding of impotence and related conditions. With an impressive ranking of 26th out of 120 journals in the Scopus category of Medicine_Urology (percentile 78th), it holds a crucial place as a Q2 journal, reflecting its substantial impact and influence in the field. Researchers, professionals, and students alike can benefit from the wealth of knowledge presented in its pages, contributing to their studies and clinical applications. While the journal is not open access, it ensures high-quality content curated by leading experts, fostering essential discourse in an often stigmatized yet significant area of health.

ANDROLOGIA is a distinguished journal published by Wiley, focusing on the vital fields of andrology, urology, and endocrinology. Since its inception in 1969, this journal has become a key resource for researchers, clinicians, and students, striving to advance the understanding of male reproductive health and related disorders. With an impressive impact factor and recognition in category quartiles such as Q2 in both Medicine (miscellaneous) and Urology for 2023, ANDROLOGIA has established itself as a leading platform, ranking 16th out of 120 in Urology. Though not an open-access journal, it offers valuable insights through a rigorous peer-review process and a commitment to disseminating high-quality research. The journal's scope is broad, encompassing all aspects of andrology and its implications within medicine, ensuring it remains relevant to the evolving landscape of health sciences. Researchers looking to publish their work or keep abreast of recent discoveries will find ANDROLOGIA an essential addition to their academic resources.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

MATURITAS is a leading international journal dedicated to promoting high-quality research in the fields of Obstetrics and Gynecology, and Biochemistry, Genetics, and Molecular Biology. Published by Elsevier Ireland Ltd, this prestigious journal boasts an impressive impact factor, consistently ranking in the Q1 quartile in both categories, underscoring its critical role in advancing scientific knowledge and clinical practices. Established in 1978 and spanning through to 2024, MATURITAS facilitates the dissemination of innovative findings and provides crucial insights into women's health and reproductive issues. Researchers, professionals, and students can engage with a wealth of resources, as the journal embraces a wide range of accessible options to foster scholarly communication. With ranks of #10 out of 209 in Medicine and #38 out of 221 in General Biochemistry, Genetics and Molecular Biology according to Scopus, MATURITAS remains at the forefront of research, making it an invaluable resource for those eager to contribute to and expand their understanding in these vital fields.

Revista Internacional de Andrologia, published by Elsevier España SLU, is a pivotal academic journal advancing the field of andrology, particularly focusing on reproductive medicine and urology. With an ISSN of 1698-031X and recognized as a reputable source within the medical community, this journal holds a Q3 ranking in both Reproductive Medicine and Urology as of 2023, reflecting its significant contribution to the field. Researchers and professionals are encouraged to engage with a diverse range of articles published annually, offering insights into current trends, innovative methodologies, and emerging challenges. Although the journal is not open access, it is an essential resource for those seeking to stay at the forefront of research and practice in andrology, making it a valuable tool for academics and clinicians alike. As the journal progresses through its converged years from 2005 to 2024, it remains committed to fostering collaboration and knowledge dissemination within the global medical community.

Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.